Skip to Content
Merck
  • Initial catabolic steps of isoleucine, the R-pathway and the origin of alloisoleucine.

Initial catabolic steps of isoleucine, the R-pathway and the origin of alloisoleucine.

Journal of chromatography. B, Biomedical sciences and applications (2001-08-03)
O A Mamer
ABSTRACT

The initial catabolic steps of isoleucine by mammals has been misunderstood and misapprehended in the scientific literature for many years. The suggestion that the interconversion of isoleucine and alloisoleucine occurs through the keto-enol racemization of their respective transaminated alpha-keto acids was first tentatively advanced by Alton Meister in the early 1950s, and accepted without hard confirming evidence by many authors. It will be shown in this brief review that isoleucine is converted to alloisoleucine with conservation of a 15N label denying the intermediacy of the alpha-keto acids, and that alloisoleucine arises as an unavoidable consequence of isoleucine transamination.

MATERIALS
Product Number
Brand
Product Description

Isoleucine, European Pharmacopoeia (EP) Reference Standard
Supelco
L-Isoleucine, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
L-Isoleucine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-Isoleucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-Isoleucine, reagent grade, ≥98% (HPLC)
SAFC
L-Isoleucine
Sigma-Aldrich
L-Isoleucine, 99%, FCC, FG
Sigma-Aldrich
L-Isoleucine, BioUltra, ≥99.5% (NT)